MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jceh.2020.02.002

Медицинская библиотека · Journal of clinical and experimental hepatology · 2020

Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.

Choudhary Narendra S, Saigal Sanjiv, Thummala Srikanth, Saraf Neeraj, Rastogi Amit, Bhangui Prashant, Srinivasan Thiagrajan, Yadav Sanjay K, Nundy Samiran, Soin Arvinder S

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Primary sclerosing cholangitis (PSC) is a progressive cholestatic disorder with liver transplantation (LT) being the only definitive treatment in end-stage disease. Recurrence of PSC after LT is a significant concern which can lead to graft loss. The aim of this study is to find out the disease recurrence and long-term outcome after living donor liver transplantation (LDLT) in PSC.

METHODS

We conducted a retrospective review of all patients undergoing LDLT for PSC at our centre. Of 2268 adult LTs from August 2004 to July 2018, 32 (1.4%) patients underwent LDLT for PSC including 6 with PSC and autoimmune hepatitis overlap. The data were reviewed to look for PSC recurrence, complications, and overall survival. All patients received tacrolimus-based immunosuppression. Data are shown as number, percentage, median, and interquartile range (IQR).

RESULT: The mean age of 32 LDLT recipients was 44 ± 12 years (males 22, females 10). At the time of transplantation, the mean child's score was 9 ± 1.6 and model for end-stage liver disease score was 18.9 ± 6.4. Ulcerative colitis was seen in 7 patients and none had cholangiocarcinoma. Majority of patients (n = 29) received right lobe graft and all but 3 underwent hepaticojejunostomy for biliary reconstruction. PSC recurrence was seen in 6 (20%) patients during a median follow-up of 59 (29-101) months, after exclusion of 2 patients with early mortality. A total of five patients died during follow-up, and one of these deaths was due to PSC recurrence. There were 2 perioperative deaths due to sepsis and 3 deaths on follow-up (sepsis in 2 and PSC recurrence in 1).

CONCLUSION

LDLT can be performed in PSC with good overall long-term outcomes.

Для цитирования: Choudhary Narendra S, Saigal Sanjiv, Thummala Srikanth, Saraf Neeraj, Rastogi Amit, Bhangui Prashant, Srinivasan Thiagrajan, Yadav Sanjay K, Nundy Samiran, Soin Arvinder S. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.. Journal of clinical and experimental hepatology. 2020. DOI: 10.1016/j.jceh.2020.02.002.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.